Ottawa needs to reset its relationship with drug developers
Politicians have to stop creating impediments to access
Read MorePosted by Nigel Rawson | May 6, 2022
Politicians have to stop creating impediments to access
Read MorePosted by Nigel Rawson | Jun 5, 2020
Canada’s separate environmental protection oversight unnecessarily delays development and approval
Read MorePosted by Nigel Rawson | Aug 29, 2018
Manufacturers must overcome several federal government hurdles before patients have access to drugs
Read MorePosted by Nigel Rawson | Jan 18, 2018
Health Canada’s revisions to the drug-pricing review board will delay or prevent access to new drugs
Read More